Preventive effects of syngeneic bone marrow transplantation on diabetic nephropathy in mice

Transplant Immunology

Volumn 22, Issue 3-4, 2010, Pages 184-190

  Ouyang, Jian ^a,b   Hu, Gang ^a   Wen, Yanting ^b   Zhang, Xin ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

AGT; Diabetic nephropathy; MCP 1; Oxidative stress; Syngeneic bone marrow transplantation; Tgf 1

Indexed keywords

ANGIOTENSINOGEN; CATALASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; STREPTOZOCIN; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; GENE EXPRESSION; HISTOPATHOLOGY; ISOGRAFT; KIDNEY HYPERTROPHY; KIDNEY INJURY; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; STREPTOZOCIN DIABETES;

ANGIOTENSINOGEN; ANIMALS; BONE MARROW TRANSPLANTATION; CATALASE; CELL DEATH; CHEMOKINE CCL2; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; KIDNEY; MALE; MESANGIAL CELLS; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77951626320     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2009.12.003     Document Type: Article

References (40)

1. Cooper M.E. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998, 352:213-219.
2. Carey R.M., Siragy H.M. The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab 2003, 14:274-281.
3. Banba N., Nakamura T., Matsumura M., Kuroda H., Hattori Y., Kasai K. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 2000, 58:684-690.
4. Ziyadeh F.N. Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol 2004, 15(Suppl 1):S55-S57.
5. Kitada M., Koya D., Sugimoto T., et al. Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes 2003, 52:2603-2614.
6. Onozato M.L., Tojo A., Goto A., Fujita T., Wilcox C.S. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int 2002, 61:186-194.
7. Thuraisingham R.C., Nott C.A., Dodd S.M., Yaqoob M.M. Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int 2000, 57:1968-1972.
8. Burt R.K., Slavin S., Burns W.H., Marmont A.M. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?. Blood 2002, 99:768-784.
9. Banerjee M., Kumar A., Bhonde R.R. Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem Biophys Res Commun 2005, 328:318-325.
10. Herrmann M.M., Gaertner S., Stadelmann C., et al. Tolerance induction by bone marrow transplantation in a multiple sclerosis model. Blood 2005, 106:1875-1883.
11. Voltarelli J.C., Couri C.E., Stracieri A.B., et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. Jama 2007, 297:1568-1576.
12. Couri C.E., Oliveira M.C., Stracieri A.B., Moraes D.A., Pieroni F., Barros G.M., et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. Jama 2009, 301:1573-1579.
13. Weibel E.R. Stereological methods: practical methods for biological morphometry 1979, Academic Press, London.
14. Wen Y, Ouyang J, Li W, Chen J, Liu Y, Meng L, et al. Time point is important for effects of syngeneic bone marrow transplantation for type 1 diabetes in mice. Transplant Proc 2009;41(5):1801-7.
15. Wen Y., Ouyang J., Yang R., et al. Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation. Biochem Biophys Res Commun 2008, 374:282-287.
16. Elkin G., Prigozhina T.B., Slavin S. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation. Exp Hematol 2004, 32:579-584.
17. Kang E.M., Zickler P.P., Burns S., Langemeijer S.M., Brenner S., Phang O.A., et al. Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established. Exp Hematol 2005, 33:699-705.
18. Hess D., Li L., Martin M., Sakano S., Hill D., Strutt B., et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003, 21:763-770.
19. Lin F. Stem cells in kidney regeneration following acute renal injury. Pediatr Res 2006, 59:74R-78R.
20. Imasawa T., Nagasawa R., Utsunomiya Y., Kawamura T., Zhong Y., Makita N., et al. Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder. Kidney Int 1999, 56:1809-1817.
21. Imasawa T., Utsunomiya Y., Kawamura T., Zhong Y., Nagasawa R., Okabe M., et al. The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol 2001, 12:1401-1409.
22. Poulsom R., Forbes S.J., Hodivala-Dilke K., Ryan E., Wyles S., Navaratnarasah S., et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 2001, 195:229-235.
23. Brezniceanu M.L., Liu F., Wei C.C., et al. Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int 2007, 71:912-923.
24. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994, 74:1141-1148.
25. Park S.Y., Song C.Y., Kim B.C., Hong H.K., Lee H.S. Angiotensin II mediates LDL-induced superoxide generation in mesangial cells. Am J Physiol Renal Physiol 2003, 285:F909-F915.
26. Ramakrishna V., Jailkhani R. Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol 2008, 45(1):41-46.
27. Tomohiro T., Kumai T., Sato T., Takeba Y., Kobayashi S., Kimura K. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy. Life Sci 2007, 80:1364-1372.
28. Zhang Z., Sun L., Wang Y., et al. Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int 2007, 73(2):163-171.
29. Singh R., Singh A.K., Leehey D.J. A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli. Am J Physiol Renal Physiol 2005, 288:F1183-F1190.
30. Giunti S., Tesch G.H., Pinach S., Burt DJ., Cooper ME., Cavallo-Perin P., et al. Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells. Diabetologia 2007, 51(1):198-207.
31. Chow F., Ozols E., Nikolic-Paterson D.J., Atkins R.C., Tesch G.H. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 2004, 65:116-128.
32. Oppenheim J.J., Zachariae C.O., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991, 9:617-648.
33. Yamamoto T., Noble N.A., Cohen A.H., et al. Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 1996, 49:461-469.
34. Border W.A., Noble N.A. Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy. Kidney Int 1998, 54:1390-1391.
35. Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 2000, 43:1205-1223.
36. Wolf G., Ziyadeh F.N. The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 1997, 29:153-163.
37. Wu Y.G., Lin H., Qi X.M., et al. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes. Int Immunopharmacol 2006, 6:445-453.
38. Lane P.H., Snelling D.M., Hollman A., Langer W.J. Puberty permits increased expression of renal transforming growth factor-beta1 in experimental diabetes. Pediatr Nephrol 2001, 16:1033-1039.
39. Okazaki Y., Yamasaki Y., Uchida H.A., Okamoto K., Satoh M., Maruyama K., et al. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor. Clin Exp Nephrol 2007, 11:77-87.
40. Zhang L., Bertucci A.M., Ramsey-Goldman R., Burt R.K., Datta S.K. Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus. J Immunol 2009, 183:6346-6358.